JP2018512440A - 皮膚細胞に対する若返り活性および／または創傷治癒活性を有する無細胞植物細胞培養懸濁液上清 - Google Patents

皮膚細胞に対する若返り活性および／または創傷治癒活性を有する無細胞植物細胞培養懸濁液上清 Download PDF

Info

Publication number
JP2018512440A
JP2018512440A JP2017554388A JP2017554388A JP2018512440A JP 2018512440 A JP2018512440 A JP 2018512440A JP 2017554388 A JP2017554388 A JP 2017554388A JP 2017554388 A JP2017554388 A JP 2017554388A JP 2018512440 A JP2018512440 A JP 2018512440A
Authority
JP
Japan
Prior art keywords
cell
fraction
plant
free supernatant
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017554388A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018512440A5 (enExample
Inventor
タレス，オスカル エクスポシト
タレス，オスカル エクスポシト
ハネフォント，アルベルト
ラシエラ，サラ ラプラナ
ラシエラ，サラ ラプラナ
ドゥアルテ，マリア マス
ドゥアルテ，マリア マス
メディナ，タリク ルイス
メディナ，タリク ルイス
ルエダ，ジェシカ ロメロ
ルエダ，ジェシカ ロメロ
Original Assignee
バイチュラス バイオテック，ソシエダ リミタダ
バイチュラス バイオテック，ソシエダ リミタダ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイチュラス バイオテック，ソシエダ リミタダ, バイチュラス バイオテック，ソシエダ リミタダ filed Critical バイチュラス バイオテック，ソシエダ リミタダ
Publication of JP2018512440A publication Critical patent/JP2018512440A/ja
Publication of JP2018512440A5 publication Critical patent/JP2018512440A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/577—Malvaceae (Mallow family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP2017554388A 2015-04-14 2016-04-11 皮膚細胞に対する若返り活性および／または創傷治癒活性を有する無細胞植物細胞培養懸濁液上清 Pending JP2018512440A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15163515.8 2015-04-14
EP15163515 2015-04-14
PCT/EP2016/057885 WO2016166047A1 (en) 2015-04-14 2016-04-11 Cell-free plant cell culture suspension supernatant with re-youth activity and/or wound healing activity over skin cells

Publications (2)

Publication Number Publication Date
JP2018512440A true JP2018512440A (ja) 2018-05-17
JP2018512440A5 JP2018512440A5 (enExample) 2019-05-23

Family

ID=52875593

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017554388A Pending JP2018512440A (ja) 2015-04-14 2016-04-11 皮膚細胞に対する若返り活性および／または創傷治癒活性を有する無細胞植物細胞培養懸濁液上清

Country Status (4)

Country Link
US (1) US12285513B2 (enExample)
EP (1) EP3283092A1 (enExample)
JP (1) JP2018512440A (enExample)
WO (1) WO2016166047A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111201012A (zh) * 2018-09-19 2020-05-26 东国制药（株） 包含积雪草不定根提取物作为有效成分的用于皮肤美白及皱纹改善的化妆品组合物
JP2023130972A (ja) * 2022-03-08 2023-09-21 株式会社 資生堂 黄ぐすみ抑制方法、黄ぐすみ抑制剤のスクリーニング方法、及び黄ぐすみ感受性の評価方法

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12440530B2 (en) 2013-03-01 2025-10-14 Envy Medical, Inc. Skin solution with solubilized bakuchiol
JP2018512440A (ja) 2015-04-14 2018-05-17 バイチュラス バイオテック，ソシエダ リミタダ 皮膚細胞に対する若返り活性および／または創傷治癒活性を有する無細胞植物細胞培養懸濁液上清
EP4190343A1 (en) * 2016-04-11 2023-06-07 Vytrus Biotech, S.L. Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment
TWI698247B (zh) * 2017-03-13 2020-07-11 大江生醫股份有限公司 茶樹癒傷組織萃取物於護膚之用途
CN107522771A (zh) * 2017-10-19 2017-12-29 宁夏大学 绒毡层细胞总蛋白提取方法
GB2568032B (en) 2017-10-25 2023-03-15 Cell Science Holdings Ltd A method of production of phytocannabinoids for use in medical treatments
FR3075641B1 (fr) * 2017-12-21 2020-05-22 L'oreal Utilisation cosmetique d’un milieu de culture acellulaire a titre d’agent actif pour le soin des matieres keratiniques
US11839682B2 (en) 2018-05-08 2023-12-12 Gat Biosciences, S.L. IMAC-enriched microalgal culture supernatant and uses thereof
US11473117B2 (en) 2018-07-24 2022-10-18 Rinati Skin, Llc System and method for the production, formulation and use of conditioned media, cultured cells and the factors included therein
IT201900004107A1 (it) * 2019-03-21 2020-09-21 Demethra Biotech S R L Fitocomplesso ed estratto di linea cellulare meristematica selezionata da Daucus carota sativa
ES2989815T3 (es) * 2019-10-15 2024-11-27 Faes Farma Sa Composiciones para administración tópica

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5119035B1 (enExample) * 1970-08-17 1976-06-14

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
US4596812A (en) 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
DE19817177A1 (de) * 1998-04-17 1999-10-21 Lohmann Rudolf Lomapharm Pflanzliche Polysaccharide mit immunstimulierender Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE19957710A1 (de) 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
JP2002253241A (ja) 2001-02-27 2002-09-10 Univ Nagoya シロイヌナズナのファイトスルフォカイン前駆体ポリペプチド、当該ポリペプチドをコードする遺伝子
FR2837385B1 (fr) 2002-03-20 2004-05-28 Rachid Ennamany Procede d'obtention de phytoalexines
FR2854328B1 (fr) 2003-04-29 2006-08-04 Rocher Yves Biolog Vegetale Composition cosmetique ou dermatologique ou pharmaceutique contenant un facteur de croissance du type vegetal de nature peptidique
EP1498475A1 (en) * 2003-07-18 2005-01-19 Meristem Therapeutics S.A. Continuous plant cell bioreactor and method for continuous plant cell culture
ITFI20050031A1 (it) 2005-02-21 2006-08-22 Stefan Coccoloni Una composizione farmaceutica atta a prevenire l'invecchiamento e l'insorgere di malattie vascolari,neoplastiche,cutanee e dell'apparato pilifero
EP2010291A2 (en) 2006-03-31 2009-01-07 Panacea Biotec Ltd. Novel compositions for hair disorders and process of preparation thereof
CH715456B1 (de) 2007-04-27 2020-04-30 Mibelle Ag Kosmetisches Produkt zur topischen Anwendung für den Schutz und die Erneuerung von Hautstammzellen, welches sich von dedifferenzierten Pflanzenzellen ableitet.
JP2012527890A (ja) 2009-05-28 2012-11-12 株式会社ウンファ 茄子科の形成層由来植物幹細胞及びこれの分離培養方法
MX2013001482A (es) 2010-08-06 2013-08-21 Genoplante Valor Plantas resistentes a patogenos y procedimientos para la produccion de las mismas.
JP2014512348A (ja) 2011-03-27 2014-05-22 アーチ ケミカルズ、インコーポレイテッド 幼弱細胞と関連するｄｎａメチル化パターンの採用を細胞にもたらす後成的ｄｎａメチル化の調節
EP2687592A1 (de) 2012-07-20 2014-01-22 greenovation Biotech GmbH Filtration von Zellkulturüberständen
EP2708596B1 (en) 2012-09-14 2016-11-09 Casen Recordati, S.L. Centella genus plant cell cultures, method of production and uses thereof
US10226495B2 (en) 2013-01-30 2019-03-12 The Beauty Cartel, Llc. Hair loss compositions and methods of making and using same
CN103976908B (zh) 2014-05-29 2016-04-27 暨南大学 一种富含植物多肽的植物提取物组合物及其在化妆品中的应用
JP2018512440A (ja) 2015-04-14 2018-05-17 バイチュラス バイオテック，ソシエダ リミタダ 皮膚細胞に対する若返り活性および／または創傷治癒活性を有する無細胞植物細胞培養懸濁液上清

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5119035B1 (enExample) * 1970-08-17 1976-06-14

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
植物の生長調節、２００４、ＶＯＬ．３９， ＮＯ．１，ＰＰ．６７−７３, JPN6020010225, ISSN: 0004234631 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111201012A (zh) * 2018-09-19 2020-05-26 东国制药（株） 包含积雪草不定根提取物作为有效成分的用于皮肤美白及皱纹改善的化妆品组合物
JP2021502953A (ja) * 2018-09-19 2021-02-04 ドン・クク・ファーム・カンパニー・リミテッド ツボクサ不定根抽出物を有効成分として含有する皮膚美白及びシワ改善用化粧料組成物
JP2023130972A (ja) * 2022-03-08 2023-09-21 株式会社 資生堂 黄ぐすみ抑制方法、黄ぐすみ抑制剤のスクリーニング方法、及び黄ぐすみ感受性の評価方法

Also Published As

Publication number Publication date
US12285513B2 (en) 2025-04-29
US20180133138A1 (en) 2018-05-17
EP3283092A1 (en) 2018-02-21
WO2016166047A1 (en) 2016-10-20

Similar Documents

Publication Publication Date Title
JP2018512440A (ja) 皮膚細胞に対する若返り活性および／または創傷治癒活性を有する無細胞植物細胞培養懸濁液上清
TWI513474B (zh) 衍生自去分化、未經誘發之摩洛哥堅果樹細胞的體外培養物之製備物、其供處置皮膚老化、發炎與療癒之用途、以及獲得其等之方法
CN104812368B (zh) 去分化植物细胞的美容用途
JP6846422B2 (ja) Ｐａｌｍａｒｉａ ｐａｌｍａｔａとジャスミンとの相乗作用的抽出物、それを含む組成物およびそれらの使用
CN104382980B (zh) 一种具有延缓衰老的星油藤茎叶提取物及其制备和应用
KR20150044607A (ko) 만능 줄기세포의 유도 방법 및 상기 방법에 의해 제조된 만능줄기세포
AU2013403885A1 (en) Method for differentiating pluripotent stem cell induced from mesenchymal stem cell into hepatocyte
JP2019023218A (ja) 亜麻の種子から抽出した中性オリゴ糖の混合物の獲得方法
DK2983691T3 (en) SYNERGIC COMBINATION OF ALANIN-GLUTAMINE, HYALURONIC ACID AND AN OATS EXTRACT AND USE THEREOF IN A COMPOSITION FOR SKIN HEALTH AND REPAIR OF SKIN LAMES
CN110604704A (zh) 一种肽类组合物化妆品及其制备方法
CN109922657A (zh) 来自爪钩草属植物的细胞系培养物
CN116987151B (zh) 一种脐带间充质干细胞上清液在皮肤修复以及抗衰老组合物中的制备方法及应用
US10053669B2 (en) Method for differentiating pluripotent stem cell induced from mesenchymal stem cell into osteoblast
CN110317774A (zh) 中草药的水性萃出物及其组合物与用途
Kim et al. Evaluation of the wound-healing activity of rice cell extracts in vitro
AU2018100588A4 (en) Cell culture mediums containing aqueous extract derived from herbal medicines
JP2023506932A (ja) 非誘導脱分化ラバンデュラ・アングスティフォリア（Ｌａｖａｎｄｕｌａ ａｎｇｕｓｔｉｆｏｌｉａ）植物細胞、その抽出物及びその美容的使用
KR101623189B1 (ko) 중간엽 줄기세포 유래 단백질을 함유하는 조직 재생용 조성물
JP5993299B2 (ja) メラノサイト分化誘導促進剤及びその使用方法
KR20200001370A (ko) 지방줄기세포배양용 배지 조성물 제조방법, 지방줄기세포배양용 배지 조성물 제조방법과 줄기세포 유효성분 3저 추출법을 이용한 줄기세포파쇄추출물(쉘드줄기세포) 제조방법, 이를 이용한 항관절염 치료용 조성물, 이를 이용한 염증억제 효과를 갖는 조성물 및 세포재생 효과를 갖는 조성물
Rangsimawong et al. Extraction method of protein and insulin-like growth factor-1 from deer antler velvets for skin rejuvenation
CN110623890A (zh) 滇黄精提取物的应用
KR102059411B1 (ko) 줄기세포파쇄추출물(논쉘줄기세포) 및 쑥추출물을 이용한 아토피 피부용 조성물 및 이를 이용한 화장품
KR102113492B1 (ko) 중간엽 줄기세포 유래 단백질을 함유하는 세포외기질 합성 촉진을 위한 조성물
Wang et al. UNRAVELING THE MYSTERY OF EXOSOMES

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190410

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190410

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200317

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20201027